A Randomized Phase II Study on the Optimization of Immunotherapy in Squamous Carcinoma of the Head and Neck

Clinical trial NCT03620123 · COMPLETED

Trial details

NCT number: NCT03620123
Sponsor: AIO-Studien-gGmbH
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Carcinoma, Squamous Cell of Head and Neck

Start date: 2018-07-16
Primary completion: 2021-06-20
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.